You are here

Article metrics

Article menu

Download PDFPDF

XML
Research Article
Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma

 

Online download statistics by month:

Online download statistics by month: December 2019 to February 2026

AbstractFullPdf
Dec 2019660
Jan 2020771
Feb 202031316
Mar 2020484810
Apr 202039398
May 2020727227
Jun 202055559
Jul 2020444518
Aug 2020515112
Sep 2020484815
Oct 202076766
Nov 202010110119
Dec 2020939316
Jan 2021868611
Feb 202111511518
Mar 202110710711
Apr 202111111221
May 2021848411
Jun 2021737313
Jul 202160606
Aug 2021515110
Sep 2021818111
Oct 2021969616
Nov 2021696814
Dec 2021666813
Jan 202294979
Feb 2022484916
Mar 202212412412
Apr 202283877
May 2022969812
Jun 202276764
Jul 2022919418
Aug 202295959
Sep 2022798115
Oct 202211111521
Nov 202221021125
Dec 202211011118
Jan 202395958
Feb 202311511723
Mar 20239910012
Apr 2023899115
May 202312312311
Jun 2023879019
Jul 202310210225
Aug 202367672
Sep 202377779
Oct 2023999915
Nov 2023788115
Dec 202359599
Jan 2024148149742
Feb 2024106106989
Mar 20249910228
Apr 2024727215
May 2024697011
Jun 2024676920
Jul 2024909119
Aug 2024687012
Sep 2024717116
Oct 2024687030
Nov 202410511120
Dec 2024878816
Jan 202511111129
Feb 202518918921
Mar 202511411613
Apr 202512112219
May 2025949424
Jun 2025545410
Jan 2026110
Feb 2026110
Total571257692665